(Q106964958)

English

Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM

clinical trial

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

clinical trial

0 references

title

Isatuximab in Combination With Lenalidomide-Dexamethasone Compared to Lenalidomide-Dexamethasone in Elderly Patients (Aged ≥70 Years) With Newly Diagnosed Myeloma: a Randomized Phase II Study (SGZ-2019-12650) (English)

0 references

0 references

0 references

0 references

contributor to the creative work or subject

Sanofi

0 references

start time

1 July 2021

0 references

end time

December 2027

0 references

number of participants

198

0 references

research intervention

(RS)-cyclophosphamide

0 references

(RS)-lenalidomide

0 references

clinical trial phase

phase II clinical trial

0 references

research subject recruitment status

not yet recruiting

0 references

minimum age

70 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT04891809

0 references

(Q106964958)

Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)